Financial Milestones. Company will pay to University the following non-cumulative, non- creditable, and non-refundable milestone achievement payments within 30 days of achieving the corresponding milestone, whether achieved by Company or a Sublicensee: Milestone $ $ $ $
Financial Milestones. Company shall pay to University the following non- cumulative and non-refundable milestone achievement payments within 30 days of achieving the corresponding milestone, whether achieved by Company or a Sublicensee.
A3.5.1. [* * *];
A3.5.2. [* * *];
A3.5.3. [* * *]; and
A3.5.4. [* * *].
Financial Milestones. Equity Not Applicable. Document Fee $10,000.00, due on the Effective Date. (One Time Fee) Transfer/Change of Control Fee (14) $150,000.00 Administrative Handling Fee (8.1.1) $10,000.00 Interest Rate (6.2) 18% Other None.
Financial Milestones. The term “Financial Milestone(s)” shall have the meaning given in Exhibit A of this Agreement.
Financial Milestones. Financial Milestones are not applicable.
Financial Milestones. If the Company’s EBIDTA for any fiscal year shall exceed $50,000,000.00 then the Company shall pay the Executive an additional cash bonus of $500,000.
Financial Milestones. The number of shares of Escrowed Iveda Common Stock to be released on each Release Date shall be adjusted as follows: • If MegaSys does not achieve at least US$300,000 post-tax net income for the year ended December 31, 2010 (after adjustment for transaction expenses paid by MegaSys in connection with this Agreement (“Transaction Expenses”) not to exceed US$300,000), then the amount of Escrowed Iveda Common Stock payable to the MegaSys Shareholders on 12/31/2011 shall be decreased by 1% for each US$3,000 below the post-tax net income target and Iveda shall be entitled to retain and cancel the Escrowed Iveda Common Stock not earned on such date. For example, if MegaSys achieves US$294,000 in post-tax net income, then the MegaSys Shareholders shall be entitled to US$705,600 of the Escrowed Iveda Common Stock and Iveda shall retain and cancel the remaining US$14,400 of the Escrowed Iveda Common Stock. • If MegaSys does not achieve at least US$300,000 post-tax net income for the year ended December 31, 2011, then the amount of Escrowed Iveda Common Stock payable to the MegaSys Shareholders on 6/30/2012 shall be decreased by 1% for each US$3,000 below the post-tax net income target and Iveda shall be entitled to retain and cancel the Escrowed Iveda Common Stock not earned on such date. • If MegaSys does not achieve at least US$300,000 post-tax net income for the year ended December 31, 2012, then the amount of Escrowed Iveda Common Stock payable to the MegaSys Shareholders on December 31, 2012 shall be decreased by 1% for each US$2,000 below the post-tax net income target and Iveda shall be entitled to retain and cancel the Escrowed Iveda Common Stock not earned on such date. • If MegaSys does not collect at least a US$1.3 million in net revenues related to the SafeCity project during the period from 7/1/2010 to 12/31/2012, then the amount of Escrowed Iveda Common Stock payable to the MegaSys Shareholders on December 31, 2012 shall be decreased by 1% for each US$50,000 below the net revenue increase target and Iveda shall be entitled to retain and cancel the Escrowed Iveda Common Stock not earned on such date. This reduction in the number of Escrowed Iveda Common Stock shall be in addition to any reductions provided for above.
Financial Milestones. Company shall pay to University the following non-cumulative and non-refundable milestone achievement payments within 30 days of achieving the corresponding milestone, whether achieved by Company or a Sublicensee. For clarity, payments will be due only once in respect of the first achievement of the milestones below for a Licensed Product, regardless of the number of Licensed Products to achieve the milestone. A3.5.2. [XXX] A3.5.3. [XXX] A3.5.4. [XXX] A3.5.5. [XXX] A3.6 Third Party Royalties. If Company is required to pay royalties to a Third Party based on Company’s manufacture, use, or sale of Licensed Product subject to one or more patents of such Third Party then the royalty Company pays to University may be reduced by [XXX] of the royalty actually paid to the Third Party provided that use of any Third Party patent is required for such manufacture, use, or sale of Licensed Product, and provided that the royalty to the University shall not fall below [XXX].
Financial Milestones. Tenant's attainment of Financial Milestones shall be measured using generally accepted accounting principles consistently applied as shown on Tenant's audited financial statements submitted to the Securities and Exchange Commission. If Tenant changes its accounting methodology then the Financial Milestones shall be renegotiated in good faith to provide Landlord with comparable protections. The Financial Milestones are as follows:
6.2.1 Tenant's Current Ratio of assets to liabilities as reflected on Tenant's Balance Sheet shall be at least 2:1.
6.2.2 Tenant's net worth as reflected on Tenant's Balance Sheet shall be equal to or greater than Ten Million Dollars ($10,000,000). As used herein, "Net Worth" shall mean as of any date, (i) Tenant's aggregate tangible assets (tangible assets shall not include assets such as goodwill, patents, trademarks, copyrights, or other intellectual property rights, franchises or research and development), minus (ii) Tenant's aggregate liabilities.
Financial Milestones. The Parties hereby agree to amend the Financial Milestones set forth in Section A3.5 of Exhibit A to the Agreement, whether achieved by Company or a Sublicensee, as follows: Section Financial Milestone Amount Payable
